MYCOLOGICS, INC.

Company Information

Company Name
MYCOLOGICS, INC.
Address
MYCOLOGICS, INC.
12635 E. MONTVIEW BLVD
AURORA, CO, 80045
Phone
n/a
URL
n/a
DUNS
190042098
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$899,576.00
10
SBIR Phase II
$746,420.00
1
STTR Phase I
$201,949.00
2

Award List

  1. N/A

    Amount: $746,420.00

    N/A

    SBIR Phase II 1999 Department of Health and Human Services
  2. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 1999 Department of Health and Human Services
  3. A NOVEL ANTIFUNGAL COMPOUND FROM CAYENNE PEPPER

    Amount: $99,582.00

    DESCRIPTION (Adapted from the application): Deep-seated mycoses are being increasingly observed in immunocompromised patients and in patients receiving aggressive cancer chemotherapy ...

    SBIR Phase I 2001 Department of Health and Human Services
  4. A NOVEL SCREEN FOR INHIBITORS OF FUNGAL GPI-ANCHORING

    Amount: $100,000.00

    Perhaps the most striking difference between fungal cells and human cells is that fungal cells are encased in a wall that protects them from a hostile external environment. The cell wall plays a dynam ...

    SBIR Phase I 2002 Department of Health and Human Services
  5. The glyoxylate cycle as a new target for antifungals

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Fungi cause a wide spectrum of disease states. The most common examples are relatively minor, localized infections of the skin and mucous membranes such as athle ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Antifungal drugs: Beta(1,6)-glucan synthesis inhibitors

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Fungi cause a wide spectrum of disease states. The most common examples are relatively minor, localized infections of the skin and mucous membranes such as athlete ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. Inhibitors of transcription of fungal glucan synthase

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Perhaps the most striking difference between fungal cells and human cells is that fungal cells are encased in a wall that protects them from an osmotically and im ...

    SBIR Phase I 2003 Department of Health and Human Services
  8. A novel yeast vaccine against Coccidioides Immitis

    Amount: $99,997.00

    DESCRIPTION (provided by applicant): Coccidioidomycosis, also known as San Joaquin Valley Fever, is a fungal disease caused by Coccidioides immitis that is endemic in portions of Southern Arizona, cen ...

    SBIR Phase I 2003 Department of Health and Human Services
  9. A novel vaccine for Aspergillus fumigatus

    Amount: $99,997.00

    DESCRIPTION (provided by applicant): Aspergillus fumigatus is a ubiqutous spore-bearing fungus that causes multiple diseases in humans. These include allergic pulmonary asthma, aspergillomas, and inva ...

    SBIR Phase I 2003 Department of Health and Human Services
  10. New drugs for the treatment of leishmaniasis

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis is a zoonosis and affects 12 million p ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government